Positive Development, a leader in developmental therapy for autistic children and their families, has secured $51.5 million in Series C funding, co-led by new investor aMoon and existing investors B Capital and Flare Capital Partners.
As the only provider delivering developmental therapy at scale, Positive Development addresses the crisis in the autism care sector, where traditional Applied Behavior Analysis (ABA) interventions can cost $50,000 to $70,000 per child per year.
The organization utilizes Developmental Relationship-Based Interventions (DRBI), combining speech, occupational, and mental health therapies with technology and real-time data. These therapies are designed to be lower in intensity, achieving measurable outcomes at an average cost that is 50% less than traditional ABA programs.
How the funding will be used: Positive Development will utilize the funds to expand its DRBI-based care model, targeting new and existing markets, and investing in new health plans and state Medicaid partnerships. Additionally, the organization will advance its proprietary technology and AI platform, enhancing the efficiency, experience, and quality of care.
New board member: As part of the Series C round, Dr. Tomer Berkovitz of aMoon has joined Positive Development’s Board of Directors.
KEY QUOTES:
“Positive Development’s ability to improve outcomes and reduce the total cost of care is directly aligned with aMoon’s mission to partner with exceptional companies who are advancing solutions that will transform healthcare and help people live healthier, better lives. Their unique developmental therapy model brings accessibility and affordability to systems in desperate need of change, and their extensive partnerships with payers and Medicaid programs showcase their success. We look forward to partnering with the team to help the company expand and scale to serve more families.”
Dr. Tomer Berkovitz, Managing Partner at aMoon
“This funding allows us to continue expanding a model that’s working for families, providers and payers. As the nation’s leading provider of developmental autism care, we’re focused on making high-quality, relationship-based support more accessible and affordable. We’re grateful to aMoon, B Capital, and all our investors for helping us move this important work forward.”
Mike Suiters, Co-founder and CEO of Positive Development
“Autistic children and families deserve affordable options that are tailored to their unique strengths and challenges, and our healthcare system needs options that don’t break the bank. Positive Development’s relationship-based, developmental therapy approach and alternative payment model are the future of autism care, and we’re excited to help the company continue to build out these important services to make care more accessible and affordable.”
B Capital Partner Adam Seabrook
